Class
All Peptides 33 GLPs 3 SARMs & Related 9 Chemicals 16 Cofactors & Longevity 6
Research area
All GLPs Weight Management
Weight Management GLPs

Retatrutide

Triple Receptor Agonist (39 Amino Acids)

Triple GIP, GLP-1 and glucagon receptor agonist developed by Eli Lilly, studied in metabolic and weight-regulation research.

Research overview
Weight Management GLPs

Semaglutide

GLP-1 Receptor Agonist
100 Da1 kDa10 kDa
His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(C18 fatty diacid via linker)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly 4113.58 Da

Long-acting glucagon-like peptide-1 receptor agonist developed by Novo Nordisk, studied extensively in metabolic and weight-regulation research.

Research overview
Weight Management GLPs

Tirzepatide

Dual GIP/GLP-1 Receptor Agonist
100 Da1 kDa10 kDa
39-amino acid sequence based on native GIP(1-42) with Aib2, Lys20-C20 fatty diacid, and multiple substitutions for GLP-1R cross-reactivity 4813.45 Da

Dual GIP and GLP-1 receptor agonist developed by Eli Lilly, studied extensively in metabolic and glucose-regulation research.

Research overview
Disclaimer: The information on peptides.fyi is provided for educational and research purposes only. This content is not intended as medical advice and should not be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before making any decisions related to your health.